Industry Experts

After having studied Bioinformatics, I started my industry journey at Immatics, developing some of the basic capabilities to analyze transcriptomic & immunpeptidomics data for target discovery of personal treatments using peptide-based approaches. After two years I moved over to CureVac SE, to help the organization to build strong capabilities to tackle all kinds of challenges around developing mRNA-based therapeutics. My current main contributions are within the drug discovery process, analyzing of clinical trial data and building AI capabilities along the entire drug development process.